Wall Street Analysts See a 142.26% Upside in Pharming Group (PHAR): Can the Stock Really Move This High?

Pharming Group N.V. Sponsored ADR (PHAR) closed the last trading session at $12.66, gaining 24.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $30.67 indicates a 142.3% upside potential.The average comprises three short-term price targets ranging from a low of $14.00 to a high of $41.00, with a standard deviation of $14.57. While the lowest estimate indicates an increase of 10.6 ...